paclitaxel,sotigalimab,nivolumab,pembrolizumab
merck,bms
['prince', 'biomarker', 'pembro']
lots of buzz re: psma-pet, lupsma and biomarkers at #asco22.. our work of serial ctc profiling of prince trial (lupsma+pembro): assoc with pet metrics and early change/clearance of psma+ ctcs may forecast outcome on lupsma 1/2 
GU Oncologist; Research at University of Melbourne and Dana-Farber/Broad